ME02479B - Nova jedinjenja kao inhibitori diacilglicerol-aciltransferaze - Google Patents
Nova jedinjenja kao inhibitori diacilglicerol-aciltransferazeInfo
- Publication number
- ME02479B ME02479B MEP-2016-159A MEP2016159A ME02479B ME 02479 B ME02479 B ME 02479B ME P2016159 A MEP2016159 A ME P2016159A ME 02479 B ME02479 B ME 02479B
- Authority
- ME
- Montenegro
- Prior art keywords
- novel compounds
- diacylglycerol acyltransferase
- acyltransferase inhibitors
- inhibitors
- diacylglycerol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1452DE2011 | 2011-05-20 | ||
| US201161503728P | 2011-07-01 | 2011-07-01 | |
| PCT/US2012/038523 WO2012162129A1 (en) | 2011-05-20 | 2012-05-18 | Novel compounds as diacylglycerol acyltransferase inhibitors |
| EP12789931.8A EP2710013B1 (en) | 2011-05-20 | 2012-05-18 | Novel compounds as diacylglycerol acyltransferase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02479B true ME02479B (me) | 2017-02-20 |
Family
ID=47217645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-159A ME02479B (me) | 2011-05-20 | 2012-05-18 | Nova jedinjenja kao inhibitori diacilglicerol-aciltransferaze |
Country Status (34)
| Country | Link |
|---|---|
| US (4) | US8859536B2 (me) |
| EP (1) | EP2710013B1 (me) |
| JP (1) | JP5844456B2 (me) |
| KR (1) | KR101919080B1 (me) |
| CN (1) | CN103703009B (me) |
| AU (1) | AU2012259044B2 (me) |
| BR (1) | BR112013029935B1 (me) |
| CA (1) | CA2836669C (me) |
| CO (1) | CO6811855A2 (me) |
| CR (1) | CR20130602A (me) |
| CY (1) | CY1118188T1 (me) |
| DK (1) | DK2710013T3 (me) |
| DO (1) | DOP2013000272A (me) |
| EA (1) | EA023030B1 (me) |
| ES (1) | ES2588748T3 (me) |
| HK (1) | HK1194738A1 (me) |
| HR (1) | HRP20161089T1 (me) |
| HU (1) | HUE028870T2 (me) |
| IL (1) | IL229488A (me) |
| LT (1) | LT2710013T (me) |
| MA (1) | MA35185B1 (me) |
| ME (1) | ME02479B (me) |
| MX (1) | MX346494B (me) |
| MY (1) | MY184553A (me) |
| PE (1) | PE20141204A1 (me) |
| PL (1) | PL2710013T3 (me) |
| PT (1) | PT2710013T (me) |
| RS (1) | RS55006B1 (me) |
| SG (1) | SG195044A1 (me) |
| SI (1) | SI2710013T1 (me) |
| SM (1) | SMT201600328B (me) |
| UA (1) | UA111360C2 (me) |
| WO (1) | WO2012162129A1 (me) |
| ZA (1) | ZA201308664B (me) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8859536B2 (en) | 2011-05-20 | 2014-10-14 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds as diacylglycerol acyltransferase inhibitors |
| NZ630436A (en) * | 2012-11-23 | 2016-08-26 | Glaxosmithkline Llc | Novel compounds as diacylglycerol acyltransferase inhibitors |
| US9796729B2 (en) | 2012-11-23 | 2017-10-24 | Glaxosmithkline Llc | Compounds as diacylglycerol acyltransferase inhibitors |
| WO2014081996A1 (en) * | 2012-11-23 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds as diacylglycerol acyltransferase inhibitors |
| CN103524431B (zh) * | 2013-09-24 | 2016-01-13 | 西安交通大学 | 3-苄基-4-喹唑啉酮类化合物及其合成方法和应用 |
| WO2015049668A1 (en) | 2013-10-03 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel compound as a diacylglycerol acyltransferase inhibitor |
| WO2015049667A1 (en) | 2013-10-03 | 2015-04-09 | Glaxosmithkline Intellectual Property (No.2) Limited | Novel compound as a diacylglycerol acyltransferase inhibitor |
| CN103880757B (zh) * | 2014-04-15 | 2016-02-24 | 上海毕得医药科技有限公司 | 一种5-羟基嘧啶-2-羧酸的合成方法 |
| WO2016181409A1 (en) | 2015-05-11 | 2016-11-17 | Cadila Healthcare Limited | Saroglitazar magnesium for the treatment of chylomicronemia syndrome - |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| CN105732461A (zh) * | 2016-02-03 | 2016-07-06 | 常州工程职业技术学院 | 5-甲氧基-6-卤代吲哚的制备方法 |
| CN106083707B (zh) * | 2016-06-01 | 2018-10-26 | 温州大学 | 一种非对称杂芳基硫醚的合成方法 |
| CN107619932B (zh) * | 2016-07-15 | 2020-08-07 | 中国科学院上海有机化学研究所 | 一种萃取组合物、萃取体系及其应用 |
| CN107619928B (zh) * | 2016-07-15 | 2020-08-07 | 中国科学院上海有机化学研究所 | 一种萃取组合物、萃取体系及其应用 |
| RU2706655C1 (ru) * | 2019-01-28 | 2019-11-19 | Акционерное общество "Гознак" (АО "Гознак") | Полимерсодержащее композиционное защищенное изделие |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090036425A1 (en) | 2007-08-02 | 2009-02-05 | Pfizer Inc | Substituted bicyclolactam compounds |
| KR101685718B1 (ko) | 2008-12-19 | 2016-12-12 | 제넨테크, 인크. | 헤테로시클릭 화합물 및 사용 방법 |
| WO2010086820A1 (en) * | 2009-02-02 | 2010-08-05 | Pfizer Inc. | 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof |
| AR075858A1 (es) * | 2009-03-18 | 2011-05-04 | Schering Corp | Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa |
| ES2513915T3 (es) * | 2009-04-24 | 2014-10-27 | F. Hoffmann-La Roche Ag | Inhibidores de la tirosina quinasa de Bruton |
| US8859536B2 (en) | 2011-05-20 | 2014-10-14 | Glaxosmithkline Intellectual Property (No.2) Limited | Compounds as diacylglycerol acyltransferase inhibitors |
| US9796729B2 (en) | 2012-11-23 | 2017-10-24 | Glaxosmithkline Llc | Compounds as diacylglycerol acyltransferase inhibitors |
-
2012
- 2012-05-18 US US14/118,976 patent/US8859536B2/en not_active Expired - Fee Related
- 2012-05-18 SI SI201230689A patent/SI2710013T1/sl unknown
- 2012-05-18 CN CN201280035792.5A patent/CN103703009B/zh not_active Expired - Fee Related
- 2012-05-18 BR BR112013029935-5A patent/BR112013029935B1/pt not_active IP Right Cessation
- 2012-05-18 PE PE2013002531A patent/PE20141204A1/es active IP Right Grant
- 2012-05-18 ES ES12789931.8T patent/ES2588748T3/es active Active
- 2012-05-18 MX MX2013013566A patent/MX346494B/es active IP Right Grant
- 2012-05-18 DK DK12789931.8T patent/DK2710013T3/en active
- 2012-05-18 RS RS20160648A patent/RS55006B1/sr unknown
- 2012-05-18 HU HUE12789931A patent/HUE028870T2/en unknown
- 2012-05-18 JP JP2014511575A patent/JP5844456B2/ja not_active Expired - Fee Related
- 2012-05-18 LT LTEP12789931.8T patent/LT2710013T/lt unknown
- 2012-05-18 SG SG2013085501A patent/SG195044A1/en unknown
- 2012-05-18 EP EP12789931.8A patent/EP2710013B1/en active Active
- 2012-05-18 PT PT127899318T patent/PT2710013T/pt unknown
- 2012-05-18 MY MYPI2013702195A patent/MY184553A/en unknown
- 2012-05-18 AU AU2012259044A patent/AU2012259044B2/en not_active Ceased
- 2012-05-18 EA EA201391737A patent/EA023030B1/ru unknown
- 2012-05-18 KR KR1020137033509A patent/KR101919080B1/ko active IP Right Grant
- 2012-05-18 ME MEP-2016-159A patent/ME02479B/me unknown
- 2012-05-18 WO PCT/US2012/038523 patent/WO2012162129A1/en active Application Filing
- 2012-05-18 UA UAA201314878A patent/UA111360C2/uk unknown
- 2012-05-18 PL PL12789931T patent/PL2710013T3/pl unknown
- 2012-05-18 CA CA2836669A patent/CA2836669C/en not_active Expired - Fee Related
-
2013
- 2013-11-18 IL IL229488A patent/IL229488A/en active IP Right Grant
- 2013-11-19 ZA ZA2013/08664A patent/ZA201308664B/en unknown
- 2013-11-20 CR CR20130602A patent/CR20130602A/es unknown
- 2013-11-20 DO DO2013000272A patent/DOP2013000272A/es unknown
- 2013-11-20 CO CO13273126A patent/CO6811855A2/es active IP Right Grant
- 2013-12-13 MA MA36566A patent/MA35185B1/fr unknown
-
2014
- 2014-08-08 HK HK14108145.1A patent/HK1194738A1/zh not_active IP Right Cessation
- 2014-09-05 US US14/478,309 patent/US9040517B2/en not_active Expired - Fee Related
-
2015
- 2015-04-24 US US14/695,206 patent/US9273069B2/en not_active Expired - Fee Related
-
2016
- 2016-01-15 US US14/996,318 patent/US9540400B2/en active Active
- 2016-08-25 HR HRP20161089TT patent/HRP20161089T1/hr unknown
- 2016-09-19 CY CY20161100926T patent/CY1118188T1/el unknown
- 2016-09-20 SM SM201600328T patent/SMT201600328B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1194738A1 (zh) | 作為二酰基甘油酰基轉移酶抑制劑的新化合物 | |
| HK1206735A1 (en) | Diacylglycerol acyltransferase inhibitors | |
| HRP20180139T1 (hr) | Supstituirani piridopirazini kao novi syk-inhibitori | |
| ZA201309561B (en) | Novel inhibitor compounds of phosphodiestarase type 10a | |
| EP2706852A4 (en) | BIPYRIDYLAMINOPYRIDINES AS SYK INHIBITORS | |
| GB201116641D0 (en) | Novel compounds | |
| EP2770987A4 (en) | NEW CONNECTIONS AS ERK HEMMER | |
| IL229487A0 (en) | New compounds as diacylglycerol acyltransferase inhibitors | |
| HRP20190099T1 (hr) | Novi spojevi kao inhibitori diacilglicerin aciltransferaze | |
| EP2916839A4 (en) | NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE HEMMER | |
| BR112013029805A2 (pt) | novos compostos como inibidores de diacilglicerol aciltransferase | |
| GB201104399D0 (en) | Novel inhibitors |